Biogen (BIIB) Share-based Compensation (2009 - 2026)
Biogen (BIIB) recorded Share-based Compensation of $77.4 million in Q2 2026, up 3.3% from $74.9 million a year earlier but down 7.9% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Share-based Compensation (2009 - 2026) Analysis & Trends
On a TTM basis, Biogen's Share-based Compensation came in at $296.3 million as of Jun 30, 2026, down 2.4% year-over-year; for FY2025, it came in at $290.8 million, down 0.1% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 8.0% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $291.2 million in FY2024 (+10.2%), $264.2 million in FY2023 (+4.0%), $254.1 million in FY2022 (+6.5%) and $238.6 million in FY2021 (+20.3%).
- Quarterly Share-based Compensation has ranged from $54.9 million in Q4 2023 to $84 million in Q1 2026 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in seven of the last eight quarters, with growth averaging 7.6%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 66.3% in Q3 2021, against a decline of 20.6% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $84 million (Q1 2026), $59.6 million (Q4 2025) and $75.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn | 77.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.40 Mn |
| Mar 31, 2026 | 84.00 Mn |
| Dec 31, 2025 | 59.60 Mn |
| Sep 30, 2025 | 75.30 Mn |
| Jun 30, 2025 | 74.90 Mn |
| Mar 31, 2025 | 81.00 Mn |
| Dec 31, 2024 | 75.10 Mn |
| Sep 30, 2024 | 72.70 Mn |
| Jun 30, 2024 | 70.60 Mn |
| Mar 31, 2024 | 72.80 Mn |
| Dec 31, 2023 | 54.90 Mn |
| Sep 30, 2023 | 62.20 Mn |
| Jun 30, 2023 | 71.50 Mn |
| Mar 31, 2023 | 75.60 Mn |
| Dec 31, 2022 | 67.20 Mn |
| Sep 30, 2022 | 63.60 Mn |
| Jun 30, 2022 | 55.70 Mn |
| Mar 31, 2022 | 67.60 Mn |
| Dec 31, 2021 | 58.80 Mn |
| Sep 30, 2021 | 55.70 Mn |
API Access
Biogen Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();